The analysis of the ultrasonic frequency-dependent backscatter coefficient of aggregating red blood cells reveals information about blood structural properties. The difficulty in applying this technique in vivo is due to the frequency-dependent attenuation caused by intervening tissue layers that distorts the spectral content of signals backscattered by blood. An optimization method is proposed to simultaneously estimate tissue attenuation and blood structure properties, and was termed the structure factor size and attenuation estimator ͑SFSAE͒. An ultrasound scanner equipped with a wide-band 25 MHz probe was used to insonify porcine blood sheared in both Couette and tubular flow devices. Since skin is one of the most attenuating tissue layers during in vivo scanning, four skin-mimicking phantoms with different attenuation coefficients were introduced between the transducer and the blood flow. The SFSAE gave estimates with relative errors below 25% for attenuations between 0.115 and 0.411 dB/ MHz and kR Ͻ 2.08 ͑k being the wave number and R the aggregate radius͒. The SFSAE can be useful to examine in vivo and in situ abnormal blood conditions suspected to promote pathophysiological cardiovascular consequences.
I. INTRODUCTION
Ultrasonic tissue characterization techniques using the radio frequency ͑rf͒ backscattered signals have received broad interest for the past 25 years. One approach is to use the magnitude and frequency dependence of the rf backscatter spectrum in order to quantify the tissue structures such as the size, acoustic impedance, and concentration of the scatterers. Many in vitro and in vivo experiments have been performed to demonstrate the utility of this approach for characterizing the eye, 1,2 liver, 3 kidney, 4 prostate, 5 and breast. 6 Recently, the frequency dependence of the ultrasound ͑US͒ backscatter coefficient was studied to assess the level of red blood cell ͑RBC͒ aggregation. 7 It is well known that when RBCs are under low shear rates ͑ Ͻ 10 s −1 ͒, they interact strongly with each other and form complex three-dimensional ͑3D͒ rouleaux structures. When the shear rate increases, rouleaux structures disaggregate. This phenomenon is normal and occurs in the circulation of many mammalian species. However, RBC hyperaggregation, an abnormal increase in RBC aggregation, is a pathological state associated with several circulatory diseases such as deep venous thrombosis, atherosclerosis, and diabetes mellitus. These pathologies inflict particular sites ͑inferior members for thrombosis, arterial bifurcations for atherosclerosis, and the foot and eye for diabetes͒. It would thus be of great interest to elucidate the role of flow-dependent rheological parameters, such as RBC aggregation, in the etiology of these pathologies in vivo and in situ with US techniques. To achieve this goal, the backscattering coefficient from blood was parametrized: two indices describing RBC aggregation, the packing factor and mean aggregate diameter, were extracted from the structure factor size estimator ͑SFSE͒. 7 The SFSE is a second-order data reduction model based on the structure factor and adapted to a dense medium such as blood. This approach is based on the analysis of the backscattered power spectrum that contains information about the size, spatial organization, concentration, and mechanical properties of scatterers ͑i.e., RBCs͒. The difficulty in using the SFSE in vivo is that the spectral content of backscattered echoes is also affected by attenuation caused by intervening tissue layers between the probe and the blood flow. More generally, US scatterer size estimation techniques for tissue characterization are facing similar challenges and several approaches to this problem have been developed. [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] In vitro attenuation measurement methods are difficult to transfer in vivo since most of the clinical studies can be performed only in a single-transducer backscatter configuration. Indeed, in vitro backscatter coefficient measurements are generally compensated with an estimation of the attenuation using transmission mode 8, 9 or reflection mode with a reflector on the opposite side of the examined tissue, 10, 11 which is difficult to implement in clinical practice. Many researchers have then attempted to improve the in vivo backscatter power spectrum estimates by assuming a priori attenuation values for the different intervening tissue layers. [12] [13] [14] Thicknesses of the intervening tissues are evaluated from the backscattered signals and typical attenuation values are assigned to each tissue, based on the results found in the relevant literature. Unfortunately, the tissue attenuation coefficients vary among patients ͑see, for example, the detailed review of the literature on tissue attenuation by Goss et al. 15 ͒ and must be determined on a patient-specific basis. Several research groups have thus developed in vivo measurement techniques to evaluate the frequency-dependent attenuation for the compensation of the backscatter power spectrum. [16] [17] [18] [19] Recently, Bigelow and co-workers [20] [21] [22] introduced a new algorithm that has the advantage to estimate simultaneously the effective radius of the tissue microstructure and the total attenuation. These two parameters were determined by using a single minimization method that fits the spectrum of the backscattered rf echoes from the region of interest ͑ROI͒ to an estimated spectrum by an appropriate model. In our previous work, this last strategy has been adapted for estimation of RBC scatterer sizes. 23 Blood structural parameters and total attenuation were determined simultaneously by using an optimization method, termed the structure factor size and attenuation estimator ͑SFSAE͒.
The goal of this paper was to further develop the SFSAE and assess its ability to evaluate three parameters ͑the packing factor, mean aggregate diameter, and total attenuation͒ with in vitro experiments mimicking in vivo conditions. To ensure that the global minimum of the optimization strategy is found, the algorithm was modified by employing an exhaustive search on the attenuation, combined with an analytical solution for the two blood structure parameters given for a fixed value of the attenuation, rather than a trust-region technique 24 used in our previous paper. 23 Porcine RBCs were first sheared in a Couette flow system, and ultrasonic rf echoes were obtained using a 25 MHz center-frequency transducer. Four skin-mimicking phantoms with different attenuation coefficients were introduced between the transducer and the blood flow. Other experiments were conducted in a tubular flow allowing to be closer to the in vivo situation.
The theoretical framework describing the SFSAE development is given in Sec. II. Section III explains the two experimental setups. Section IV presents results and compares the new SFSAE with the SFSE with compensation for attenuation. The validation of the method is finally discussed in Sec. V.
II. STRUCTURE FACTOR SIZE AND ATTENUATION ESTIMATOR "SFSAE…
Ultrasonic scattering from blood is mainly caused by the RBCs. Indeed, blood can be mechanically described as a colloidal suspension of RBCs in plasma. RBCs constitute the vast majority ͑97%͒ of the cellular content of blood and occupy a large volume fraction ͑hematocrit͒ of 35%-45% under normal conditions. These RBCs cannot be treated as independent scatterers since particle interactions ͑collision, attraction, deformation, and flow dependent motions͒ are strong. The theoretical model of US backscattering by blood that we developped 7 is based on the particle approach, 25, 26 which consists of summing contributions from individual RBCs and modeling the RBC interaction by a particle paircorrelation function. Assuming that all the RBCs in the insonified blood are identical and using the Born approximation ͑weak scattering͒, the model predicts that the theoretical backscatter coefficient of blood is given by 23 BSC theor ͑k͒ = m b ͑k͒S͑k͒A͑k͒, ͑1͒
where k is the wavenumber, m is the number density of RBCs in blood, b is the backscattering cross section of a single RBC, S is the structure factor describing the spatial organization of RBCs, and A is the frequency-dependent attenuation function. The number density of RBCs m can be estimated by measuring the hematocrit H by microcentrifugation; m is then given by m = H / V s , where V s is the volume of a RBC ͑typically 87 m 3 ͒. The backscattering crosssection b of a weak scatterer small compared to the wavelength ͑Rayleigh scatterer͒ can be determined analytically as follows:
where ␥ z = ͑Z RBC − Z plasma ͒ / Z plasma is the fractional variation of impedance between the RBC and its suspending medium ͑i.e., the plasma͒. The structure factor S is by definition the Fourier transform of the pair-correlation function 26 g and can be approximated by its second-order Taylor expansion 7 in k as
In this expression, g͑r͒ represents the probability of finding two particles separated by a distance r. W is the lowfrequency limit of the structure factor ͓͉S͑k͉͒ k→0 ͔ called the packing factor. 26, 27 R is the radius of 3D RBC aggregates assumed to be isotropic. We introduce D = R / a as the isotropic diameter of an aggregate ͑expressed in number of RBCs͒ with a the radius of one RBC sphere-shaped model of volume V s . The attenuation function A is given by
where c is the mean speed of sound in the intervening tissue layers, f is the frequency in MHz, and ␣ 0 is the attenuation coefficient ͑in dB/MHz͒ defined by ␣ 0 = ͚ i ␣ i e i , where ␣ i and e i are, respectively, the intervening tissue layer attenuations ͑in dB/cm MHz͒ and thicknesses. One can note in Eq. ͑4͒ the coefficient 8.68 that expresses unit conversion from decibels to neper: ␣ 0 ͓Np/ MHz͔ = ␣ 0 ͓dB/ MHz͔ / 8.68. According to the above equation, we thus assume, as a first approximation, that the attenuation increases linearly with the frequency: ␣͑f͒ = ␣ 0 f / 8.68. Altogether, we obtain the following expression for the theoretical backscatter coefficient from blood:
͑5͒
In particular, for a given value of the wavenumber k ͑equiva-lently, a given value of the frequency f͒ and a given value of the attenuation coefficient ␣ 0 , BSC theor ͑k͒ is a linear function of the variables W and D 2 . The measured backscatter coefficient reported in this study was computed as
In Eq. ͑6͒, the mean backscattered power spectrum P meas was obtained by averaging the power spectra of 20 backscattered echoes from blood. The mean power spectrum P ref was obtained from a reference sample of non-aggregated RBCs at a low hematocrit of 6% ͑i.e., Rayleigh scatterers͒. 28 In this case, 20 echoes were also averaged. The backscatter coefficient of this reference sample BSC ref was estimated by using the expression of the Perkus-Yevick packing factor for spheres W PYs ͑that is a function of the hematocrit H͒ as follows: 26, 27 
This reference sample was used to compensate the backscattered power spectrum P meas for the electromechanical system response, and the depth-dependent diffraction and focusing effects caused by the US beam. The packing factor W, aggregate diameter D, and total attenuation along the propagation path ␣ 0 were determined by matching the measured BSC meas given by Eq. ͑6͒ with the theoretical BSC theor given by Eq. ͑5͒. For this purpose, we searched values of ͑W , D 2 , ␣ 0 ͒ ͑0,ϱ͒ ϫ ͑0,ϱ͒ ϫ ͓0,1͔, W and D being variables without dimension and ␣ 0 expressed in dB/MHz, minimizing the cost function which synthesizes all of the wavenumbers k i ͑i =1¯N͒ within the −20 dB bandwidth of P meas :
͑8͒
The cost function had in the majority of cases reported in this study one minimum, as was observed by plotting the cost function surface F͑W , D 2 , ␣ 0 ͒ with varying values of ␣ 0 . An example is given in Fig. 1 . That is why a simple minimization routine lsqnonlin in MATLAB ͑The MathWorks, Inc., Natick, MA͒, i.e., a trust-region method based on the interiorreflective Newton method, 24 was first employed in our previous paper. 23 Nevertheless, on a possibility of the appearance of several minima, an exhaustive search on the value of ␣ 0 was employed in this paper in order to ensure that the global minimum is found. If the value of ␣ 0 is fixed, a quadratic function of the two variables W and D 2 is obtained, as can be seen from Eq. ͑8͒, and by calculating its critical points, a system of two linear equations of two unknowns can be easily solved. One can show using the Cauchy-Schwartz' inequality that the determinant of this system never vanishes ͑unless all frequencies are equal͒ and thus that the solution is unique. If the unique solution of this system denoted ͑W
␣ 0 ͒ has no global minimum on ͑0,ϱ͒ ϫ ͑0,ϱ͒ ͑with the value of ␣ 0 fixed͒. Also, this case means that the value of ␣ 0 has to be rejected, since it is meaningless. Otherwise, the global minimum of 
The optimal value of ␣ 0 can thus be obtained upon sweeping the interval ͓0,␣ * ͔. In our tests, we started the exhaustive search with a step of 10 −5 dB/ MHz. Then, the step was iteratively decreased by a factor of 10 −1 dB/ MHz, while the search is performed on the interval of length twice the preceeding step around the best value obtained so far. 
III. METHODS

A. Blood sample preparation
Blood from two different pigs were used for the two experiments in a Couette device and in a tube. This fresh porcine whole blood was obtained from a local slaughter house and anticoagulated with 3 g / l of ethylene diamine tetra acetic acid ͑EDTA͒. Then the whole blood was centri- fuged and the plasma and buffy coat were removed. Two blood samples were then prepared for each experiment: ͑i͒ a H6 reference sample, which was a 6% hematocrit nonaggregating RBCs resuspended in physiological saline solution, and ͑ii͒ a 40% hematocrit T40 test sample, which consisted of RBCs resuspended in plasma to promote aggregation.
B. In vitro experiments
In vitro experiments in a Couette flow system
"Couette device… US measurements were first performed in a Couette device to produce a linear blood velocity gradient at a given shear rate ͑see Fig. 1 in Ref. 29͒ . The system consists of a rotating inner cylinder with a diameter of 160 mm surrounded by a fixed concentric cylinder of diameter 164 mm. A 60 ml blood sample was sheared in the 2 mm annular space between both coaxial cylinders. An US scanner ͑Vevo 660, Visualsonics, Toronto, Canada͒ equipped with the RMV 710 probe was used in B-mode. The oscillating singleelement focused circular transducer had a center frequency of 25 MHz, a diameter of 7.1 mm, and a focal depth of 15 mm. We acquired RF data from this scanner at a sampling frequency of 250 MHz with 8 bit resolution ͑Gagescope, model 8500CS, Montreal, Canada͒. The probe was mounted in the side wall of the fixed outer cylinder and was positioned to have its focal zone at the center of the gap between both cylinders. To ensure ultrasonic coupling, the hole within the outer stationary cylinder ͑containing the probe͒ was filled with a liquid agar gel based mixture. When solidified, this gel was cut to match the curvature of the cylinder to avoid any flow disturbance. The gel was a mixture of distilled water, 3% ͑w/w͒ agar powder ͑A9799, Sigma Chemical, SaintLouis, MO͒, 10% ͑w/w͒ glycerol, and a specific concentration of 50 m cellulose scattering particles ͑S5504 Sigmacell, Sigma Chemical, Saint-Louis, MO͒ that determined the attenuation coefficient. Five experiments were performed with five mixtures having SigmaCell ͑SC͒ concentrations varying from 0% to 1% ͑w/w͒. The 0% concentration constituted the non-attenuating gel and the four other mixtures mimicked skin attenuations.
All US measurements were made at room temperature. Prior to each measurement, the T40 blood was sheared at 200 s −1 during 30 s to disrupt RBC aggregates. The shear rate was then reduced to residual values of 5, 10, 20, 30, and 50 s −1 for 90 s until an equilibrium in the state of aggregation was reached. For each shear rate, 20 B-mode images were constructed from acquired rf echoes each 4 s for a total period of analysis of 80 s. Each image contained 384 vertical lines. For 180 vertical lines at the center of the B-mode images, echoes were selected with a rectangular window of axial length 0.4 mm at 20 depths every 0.031 mm ͑i.e., with 92% overlap between windows͒. For each depth, the power spectra of the backscattered rf echoes were averaged over 20 acquisitions ͑corresponding to the 20 acquired B-mode images͒ to provide P meas . This protocol was repeated five times with the same blood and with each of the five agar-based phantoms.
Then, the T40 blood was removed and the H6 sample was introduced in the Couette device. The H6 sample was sheared at 50 s −1 and coupled with the 0% SC concentration agar gel. Echoes were windowed as for the H40 sample at the same depths and their power spectra were averaged over 20 acquisitions to obtain P ref . This reference power spectrum allowed to normalize the average power spectrum P meas ͓as described in Eq. ͑6͒, Sec. II͔.
In vitro experiments in a tube
In order to be closer to in vivo conditions, US measurements were also performed in a tubular flow device. The experimental test section was an horizontal tube made of polyvinyl alcohol ͑PVA͒ cryogel. This tube had an internal diameter of 4.9 mm and a length of 10 cm, and was immersed in a tank filled with degassed water at room temperature. The US measurements were made at a position 7 cm from the tube entrance with the Vevo 660 US scanner. The transducer focal point at 15 mm was positioned at the middle of the tube, imaged in the longitudinal plane. The T40 blood sample was circulated in the PVA tube using a double syringe pump ͑Harvard PHD 2000͒ at a constant flow rate from the outflow syringe, to the tube and the second inflow syringe. In order to ensure that the RBCs are disaggregated at the tube entrance, the T40 sample blood passed through a small recipient containing a magnetic stirrer just before entering the PVA tube, as indicated in Fig. 2͑a͒ . Similarly to the Couette experiments ͑Sec. III B 1͒, a layer of gel was placed between the probe and the tubular flow. Five experiments were successively performed on the same blood with five mixtures having SC concentrations: 0%, 1%, 1.5%, 2%, and 2.5% ͑w/w͒.
The flow rate was chosen equal to 5 ml/ min to promote RBC aggregation and when 30 ml of blood had circulated in the tube, 20 B-mode images were constructed for 80 s. The data were processed as described for the in vitro experiment in the Couette device, except that echoes were selected with a rectangular window of length 0.4 mm at 65 depths every 0.031 mm ͑again with 92% overlaps͒. A reference measurement was done by using the H6 sample circulating in the tube at a flow rate of 5 ml/ min. Echoes were windowed as for the H40 sample at the same 65 depths and their power spectra were averaged over 20 acquisitions to obtain P ref .
One can note here that P ref allow to compensate P meas not only for the electromechanical system response, and the depth-dependent diffraction and focusing effects caused by the US beam, but also for the US response of the PVA cryogel tube.
Attenuation measurements for comparison with the SFSAE attenuation estimates
The attenuation coefficients of the reference ͑0% SC͒ and of the skin-mimicking phantoms were determined by using a standard substitution method. The Vevo 660 US scanner equipped with the same RMV 710 25 MHz transducer was used in M-mode and in transmission/reception with a reflector on the opposite side of the phantom for reflection measurements. Reflected signals were recorded both with and without the agar gel sample in the acoustic path. The attenuation coefficient was then estimated using a log spectral difference technique. 30 For a given concentration of SC, measurements were obtained from two different sample thicknesses, and for each, six regions were scanned for averaging purpose. In our experimental devices, thicknesses of skin-mimicking phantoms e SC were fixed to 1.3 cm in the case of the Couette device and 0.45 cm for the tubular flow experiments. Values of the average attenuations ␣ SC expressed in dB/cm MHz and of the attenuation coefficients ␣ SC e SC expressed in dB/MHz for the Couette and tube experiments are reported in Table I . As it can be observed in this table, attenuation coefficients of skin-mimicking phantoms were in the same range as the human dermis ͑which is 0.21 dB/ MHz at 14-50 MHz considering a 1 mm dermis thickness 31 ͒. For the Couette device configuration, blood attenuation was also measured at different shear rates in the reflection mode. The gel had a 0% SC concentration, the probe was used in M-mode and the rotating inner cylinder was used as the reflector. For each shear rate, acquisitions of 20 rf lines were performed both with blood and with water in the Couette device. The water acquisition was used for normalization. For each acquisition, blood attenuation was estimated using the log spectral difference technique. 
IV. RESULTS
A. In vitro experiments in the Couette device Figure 3 shows the typical BSC meas as a function of frequency for different residual shear rates in the case of 0% SC ͑i.e., reference measurements͒. Also represented are corresponding fitted curves obtained with the SFSE after compensation for predetermined values of blood attenuation. Fig. 4 . The attenuations given in Fig. 4 correspond to the reference total attenuations ␣ ref i.e., the sum of ␣ SC and ␣ blood estimated in the reflection mode as shown in Sec. III B 3. For all shear rates, an increase in the total attenuation has the effect of decreasing the amplitude of the BSC meas at all frequencies and also has an effect of moving the peak of the BSC meas at lower frequencies. It is very interesting to observe how attenuation influences the wellknown quasi-Rayleigh backscattering behavior of disaggregated RBCs ͑i.e., at a shear rate of 50 s −1 ͒. Indeed, for the 50 s −1 shear rate combined with the 0% SC concentration ͑reference measurement͒, the frequency dependence of the BSC meas is close to f 4 and is thus quasi-linear on our log compressed scale, as expected. In the presence of attenuation, the frequency dependencies of the BSC meas are drastically modified. Figure 5 shows quantitative images superimposed on the gray-scale B-mode images of the blood sheared at 10 s −1 in the Couette device. The color of each pixel was assigned based on the value of the parameters estimated by the SFSE with the 0% SC phantom and by the SFSAE with the four skin-mimicking phantoms. The color bars relate the pixels in the quantitative images to the estimated parameters ͑W, D, and ␣ 0 ͒ in the chosen ROI. The black pixels in the ROI correspond to rejected solutions of the optimization method ͑when the estimated packing factor W or diameter D 2 was found equal to zero, which is unrealistic͒. A clear distinction between images of the estimated total attenuation with the four skin-mimicking phantoms is apparent, which was expected, whereas images of the estimated parameters W and D are quite similar, which was also wished.
For each residual shear rate, quantitative images for the three parameters W, D, and ␣ 0 were constructed. The average estimates are summarized in Fig. 6 . The lower and upper error bars for relative errors correspond to
where X represents one of the estimated parameters W, D, or ␣ 0 . For all shear rates and all skin-mimicking phantoms, the SFSAE gave quantitatively satisfactory estimates of W and D with relative absolute errors below 25%, except for the shear rate of 5 s −1 and the 0.25% SC skin-mimicking phantom. The use of the SFSAE when there is little attenuation ͑i.e., the 0% SC phantom͒ was also investigated. Figure 7 presents the averaged parameters W , D , and ␣ 0 obtained from the SFSAE with the 0% SC phantom. In this experiment, the total attenuation came mainly from the blood Fig. 8 . The relative errors are below 25% for all shear rates and all skinmimicking phantoms. Figure 9 shows quantitative images superimposed on the gray-scale B-mode images of tubular blood flow for each skin-mimicking phantom. As observed in the Couette experiment, a clear distinction between images of the estimated total attenuation is apparent, whereas images of the estimated parameters W and D are quite similar.
B. In vitro experiments in the tubular flow device
In order to know the shear rate profile in the tube, a speckle tracking method 32 was used to obtain the displacement fields of RBCs, as shown in Fig. 2͑b͒ . The displacement of the speckle pattern between each frame is then related to the velocity through the time elapsed between the images. The mean velocity profile across the tube was fitted to the following simple power-law model:
where v͑r͒ is the mean velocity at radius r, R is the radius of the tube, v max is the maximum velocity, and n is the powerlaw exponent ͑n = 2 for parabolic flow͒. As expected, the velocity profile was slightly blunted due to RBC aggregation with n = 2.99 ͓see Fig. 2͑b͔͒ . The shear rate profile, ␥͑r͒, was deducted from this velocity profile by computing the derivative of v͑r͒:
Five shear rates were selected on the shear rate profile ͑i.e., 0.1, 0.3, 1, 1.5, and 2 s −1 ͒ corresponding to specific depths ͓see Fig. 2͑b͔͒ and thus corresponding to specific blood thicknesses ͑i.e., 2.7, 2.9, 3.4, 3.6, and 3.8 mm͒. For each arbitrarily chosen to be equal to 0.028 dB/ mm MHz. This point will be discussed later in Sec. V A. Figure 10 summarizes these results. The SFSAE gave estimates of W , D , and ␣ 0 with relative errors below 25% for all skin-mimicking phantoms at shear rates between 0.3 and 2 s −1 . Worse estimates were obtained for the smallest shear rate of 0.1 s −1 : for 1% and 1.5% SC concentrations, relative errors for W were 61% and 32%, respectively, those for ␣ 0 were 56% and 47%, respectively, whereas those for D remained below 20%.
V. DISCUSSION
A. The difficulty to measure the blood attenuation in a tube flow device
The following discussion intends to explain why blood attenuation values in function of the shear rate cannot be obtained directly by measurements in a tube by a standard substitution method. The ideal protocol would be to realize blood attenuation measurements on a Couette apparatus ͑as performed in Sec. III B 3͒ for the different shear rates present in the tube. In our experiments, the tube was not long enough ͑kinetic time͒ to obtain the same aggregate sizes as in the Couette device, that is why we chose a mean blood attenuation equal to 0.028 dB/ mm MHz corresponding to the average of blood attenuations estimated with the Couette device for the different shear rates ͑see Sec. III B 3͒.
B. Limitations of the SFSAE with respect to kR and attenuation
For both Couette and tubular flow devices, the SFSAE gave good estimates of W, D, and ␣ 0 with relative errors below 25% for all skin-mimicking phantoms and for all shear rates, except for the smallest shear rates and the smallest attenuations ͑0.115 dB/ MHz for the Couette and 0.142 dB/ MHz for the tube͒: relative errors for W were around 50% ͑Couette͒ and 61% ͑tube͒, for ␣ 0 around 48% ͑Couette͒ and 56% ͑tube͒, for D below 25% as indicated in Figs. 6 and 10. In the tube experiment, one can also notice that relative errors for ␣ 0 were always worse at the smallest shear rate ͑0.1 s −1 ͒ for all skin-mimicking phantoms. For the peculiar case when there is little attenuation ͑i.e., Յ0.06 dB/ MHz͒, the SFSAE did not give accurate results ͑absolute relative errors reaching 42% for W and 211% for ␣ 0 ͒.
For the Couette device, the correlation coefficients given in Tables III-V reveal that the SFSAE produced quite good fits to data for all skin-mimicking phantoms and all shear rates, i.e., 0.74Յ r 2 Յ 0.91. Nevertheless, for both SFSE and SFSAE models, the smallest r 2 values occurred at the lowest shear rate of 5 s −1 . It is illustrated by fits of SFSE and SF-SAE models in Fig. 4 that are worse at 5 s −1 ͑in comparison with fits at 10 and 50 s −1 ͒, especially for the largest attenuation.
Considering the correlation coefficients and the accuracy of the estimates, both SFSE and SFSAE seem to reach their limit of applicability for large aggregate sizes: for the Couette experiments, typically D ref = 10.11 in Table II ͑i.e., kR = 2.88 with f = 25 MHz͒ and for the tube experiments, typically D ref = 7.29 in Fig. 10 ͑i.e., kR = 2.08͒. To conclude, the SFSAE performed well for kR Ͻ 2.08 and for total attenuations between 0.115 and 0.411 dB/ MHz. In the following, these bounds will define the SFSAE validity domain, i.e., the domain where the SFSAE gives accurate estimates of W, D, and ␣ 0 .
It is interesting to note that the limitations of the SFSAE can be used to interpret the attenuation quantitative images obtained in the tubular flow device ͑Fig. 9͒. Indeed, these images are less homogeneous compared to those obtained in the Couette device since the standard deviations for attenuation were between 0.052 and 0.082 dB MHz for the tube and between 0.033 and 0.063 dB/ MHz for the Couette. It is clearly linked with the presence of shear rates ͑Ͻ0.3 s −1 ͒ in the tube experiments that result in large aggregate sizes outside the validity domain of the SFSAE.
C. Comparison of the SFSAE and SFSE with compensation for attenuation
For the Couette experiments, relative errors for W and D were generally below 25% ͑except for one value͒ with the SFSAE ͑Fig. 6͒ and with the SFSE with attenuationcompensation ͑Fig. 8͒. For W at 5 s −1 and a 0.25% SC, the SFSAE was not in its validity domain. In the SFSAE validity domain, the accuracy of the estimates obtained with the SF-SAE was thus as satisfactory as those obtained with the SFSE with attenuation-compensation. The SFSAE has the major advantage to be easily applicable in vivo contrary to the SFSE attenuation-compensation method, needing the attenuation and thickness of the tissue intervening layers to be known.
D. Rejected solutions
In Figs. 5 and 9, one can notice the rejected solutions represented in black pixels. These solutions were rejected because their estimated diameters were equal to 0 ͑whereas the estimated packing factors never vanish͒. One might think that these rejected solutions come from cost functions having several local minima. Several cases of rejected solutions were studied and their corresponding cost functions had always a unique global minimum ͑data not shown͒.
To better understand what happened in these special cases, Fig. 11͑a͒ represents two backscatter coefficients for blood sheared at 20 s −1 in the Couette flow device and measured with the 0.25% SC concentration phantom. Although both experimental backscatter coefficient were quite similar, the corresponding fitted models with the SFSAE gave two very different estimates of W, D, and ␣ 0 . One estimation corresponds to a kept solution and the other to a rejected solution with an estimate of D equal to 0. In Fig. 12 the mean values of W , D , and ␣ 0 are summarized for the kept and rejected solutions estimated with the SFSAE for all shear rates and for the 0.25% SC concentration phantom. It can be observed, for the rejected solutions, that both W and ␣ 0 were overestimated. This phenomenon can be explained by the difficulty to evaluate simultaneously three parameters that have the same effect on the backscatter coefficient as explained below. Figure 11͑b͒ illustrates the respective effect of varying W, D, and ␣ 0 on the backscatter coefficient. We arbitrarily selected a shear rate of 50 s −1 ͑i.e., a quasidisaggregated case͒ and no SC attenuation. An increase in W has the effect of increasing the amplitude of the backscatter coefficient at all frequencies; whereas increasing D has an effect on the frequency dependence. But more interesting is to observe that an increase in ␣ 0 has the effect of decreasing the amplitude and also of modifying the frequency dependence of the backscatter coefficient. It is thus difficult to estimate simultaneously these three parameters, because a modification in ␣ 0 plays the same role ͑i.e., effects on the amplitude and the frequency dependence͒ that modifications in W ͑i.e., amplitude͒ and D ͑i.e., frequency dependence͒. The typical example given in Fig. 11͑a͒ and parameter values presented in Fig. 12 can now be better understood. When the optimization method gives an unrealistic estimate of D equal to 0, the frequency dependence of the backscatter coefficient is only given by ␣ 0 , which is overestimated. But since increasing ␣ 0 has also the effect of decreasing the amplitude of the backscatter coefficient, the overestimation of ␣ 0 goes with the overestimation of W. Figure 13 gives the percentage of rejected solutions in the ROIs ͑i.e., 20 depths and 180 rf lines for the Couette, as shown in Fig. 5 , and three depths and 180 rf lines for the tube͒ at each shear rate for both Couette and tubular flow devices. For both devices, it can be clearly observed that percentages of rejected solutions are highest for experiments with the smallest attenuation ͑0.25% SC for the Couette and 1% SC for the tube͒ and with the highest shear rate, i.e., with quasi-disaggregated RBCs ͑50 s −1 for the Couette and 2 s −1 for the tube͒. The rejected solutions were thus more important when the frequency dependence was nearly Rayleigh. In our previous study, 23 we did not reject solution, that is why bad estimates were obtained for quasi-disaggregated RBCs. The rejection of some solutions was vital for having accurate results in the cases of quasi-disaggregated RBCs and of small total attenuation.
E. On the use of the SFSAE in vivo
The accuracy of the SFSAE was quantitatively demonstrated in a validity domain. One might question the use of this method in vivo. Although the SFSAE gave estimates with large errors for kR Ͼ 2.08 and ␣ 0 Յ 0.06 dB/ MHz, the estimated parameters presented in Figs. 6 and 10 experiments, since the SFSAE is able to predict the aggregation state and attenuation tendencies.
VI. CONCLUSION
Aggregating porcine RBCs were examined using US via in vitro experiments in Couette and tubular flow devices. Estimates of blood structural parameters and total attenuation were made from the frequency dependence of the US backscatter using the SFSAE model. This study revealed that the SFSAE provided accurate quantitative estimates of blood microstructure parameters W and D for kR Ͻ 2.08 and for total attenuations between 0.115 and 0.411 dB/ MHz. In this validity domain, the results obtained with the SFSAE was quantitatively as satisfactory as those obtained with the SFSE with attenuation-compensation ͑i.e., when prior information on the attenuation is available͒. Outside this validity domain, the SFSAE was able to give the aggregation state tendency.
The SFSAE has been shown to be able of estimating blood backscattering properties in the presence of tissue intervening layers. This method is easily applicable in vivo because of the simultaneous estimation of the blood structural properties and total attenuation, contrary to the SFSE attenuation-compensation method, needing the attenuation and thickness of the tissue intervening layers to be known. Future works should focus on in vivo and in situ assessment of the pathophysiological impact of abnormal RBC aggregation on the cardiovascular system.
